To provide a method of identifying a patient eligible for intensification of heart failure therapy.SOLUTION: A method of identifying a patient eligible for intensification of heart failure therapy is provided, the method comprising: (a) measuring the level(s) of at least one marker selected from a group consisting of creatinine, urea, sodium, glucose, HbA1c (glycated hemoglobin), hemoglobin, and hematocrit in a sample collected from a patient with heart failure receiving a BNP-type peptide guided heart failure therapy; and (b) comparing the level(s) of the marker(s) measured in the step (a) with a reference level(s).SELECTED DRAWING: None
BIOMARKERS FOR RISK ASSESSMENT AND TREATMENT MONITORING IN HEART FAILURE PATIENTS GUIDED BY NATRIURETIC PEPTIDES